A Clinical Research of CD70-targeted CAR-NKT Cells (CGC738) Therapy in RCC
NCT06870279 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 28
Last updated 2025-04-24
Summary
This is a phase I, open-label, single-arm study conducted to evaluate the efficacy, safety and PK of CGC738 in the treatment of advanced clear cell renal cell carcinoma (ccRCC).
Conditions
- Advanced Clear Cell Renal Cell Carcinoma
Interventions
- DRUG
-
CGC738
CAR-NKT Cells treatment
Sponsors & Collaborators
-
RenJi Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-25
- Primary Completion
- 2026-08-01
- Completion
- 2026-12-31
More Related Trials
-
A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T
NCT05468190 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of GV20-0251 in Participants With Solid Tumor Malignancies
NCT07070518 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor (Lung, Liver and Stomach)
NCT02862028 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Phase I Study of SSGJ-612 in Patients With Advanced Solid Tumors
NCT07032298 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid Tumors
NCT06612840 ·Status: RECRUITING ·Phase: PHASE1
-
A Multicenter Trial Comparing Multi-course Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
NCT00705627 ·Status: UNKNOWN ·Phase: PHASE3
-
An Open-label Study of SG1827 in Subjects With Advanced Solid Tumors
NCT06076291 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Adjuvant vs Surgery Only in Early-stage Recurrent NPC
NCT06228079 ·Status: RECRUITING ·Phase: PHASE3
-
Personalized KSX01-TCRT in Patients With Advanced Solid Tumors
NCT06150365 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Clinical Study on the Safety and Efficacy of CAR-T/CAR-NK Cells in the Treatment of Recurrent Refractory or Unresectable Solid Tumors
NCT06572956 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-T
NCT05620732 ·Status: RECRUITING ·Phase: NA
-
U87 CAR-T in Patients With Advanced Head and Neck Tumors
NCT06614686 ·Status: RECRUITING ·Phase: PHASE1
-
CNG Staging Compared With 8th UICC of NPC for Treatment Decision-marking and Selection of Chemotherapy and Radiotherapy
NCT03529279 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Postoperative Adjuvant Therapy for Non-clear Renal Cell Carcinoma With High-risk Recurrence Factors
NCT05768464 ·Status: RECRUITING ·Phase: PHASE2
-
SCT200 Injection in Patients With Head and Neck Squamous Cell Carcinoma
NCT03744208 ·Status: UNKNOWN ·Phase: PHASE2
-
KSH01-R02-101 Solid Tumors
NCT05580796 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SSGJ-705 Monotherapy in Patients with Advanced Malignant Tumors
NCT06390774 ·Status: RECRUITING ·Phase: PHASE1
-
A Clinical Study to Evaluate Safety, Tolerance, Pharmacokinetics and Efficacy of Sc610 Injection for Treating Advanced Urinary System Tumors
NCT05633589 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors
NCT07050459 ·Status: RECRUITING ·Phase: PHASE1
-
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
NCT05420545 ·Status: UNKNOWN ·Phase: PHASE1
-
NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors
NCT05382377 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
U87 CART in Treatment of Advanced Solid Tumor
NCT05605197 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase I Study of NK042 Cell Injection in Advanced Solid Tumors
NCT06773091 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase 1 Study of SSGJ-709 in Patients With Advanced Malignant Tumors
NCT07016490 ·Status: RECRUITING ·Phase: PHASE1
-
Toripalimab Plus Etoposide and Platinum-based Chemotherapy for Genitourinary Small Cell Carcinoma
NCT05760053 ·Status: RECRUITING ·Phase: PHASE2